lupus nephritis and biomarkers Archives

Abstract Number: 696 • ACR/ARP Annual Meeting 2019
The Performance of a Renal Activity Index in Lupus Nephritis in Induction Therapy
Najla Aljaberi¹, Qing Ma ², Theresa Hennard ³, Arjun Mathur ⁴ and Hermine Brunner ⁵, ¹Divison of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ³Division of Rheumatology, Cincinnati Children's Hospital and Medical Center, Cincinnati, OH, ⁴Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁵Pediatric Rheumatology Collaborative Study Group (PRCSG), Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Background/Purpose: Lupus nephritis (LN) is associated with high morbidity and mortality. Current standard tools to monitor LN are suboptimal compared to the invasive renal biopsy.…
Abstract Number: 1583 • ACR/ARP Annual Meeting 2019
Prognostic Value of Urinary Biomarkers for the Developing of End Stage Renal Disease in Patients with Systemic Lupus Erythematosus
Jose A Gómez-Puerta¹, Tomás Urrego ², Blanca Ortiz Reyes ³, Adriana Vanegas-García ⁴, Carlos H Muñoz-Vahos ⁴, Luis A González ⁴ and Gloria Vasquez ⁵, ¹Rheumatology Department, Hospital Clinic de Barcelona, Barcelona, Catalonia, Spain, ²Grupo de Inmunología Celular e Inmunogenética, Universidad de Antioquia, Medellín, Antioquia, Colombia, ³Grupo de Inmunología Celular e Inmunogenética, Facultad de Medicina, Universidad de Antioquia, Medellín, Antioquia, Colombia, ⁴Grupo de Reumatología, Universidad de Antioquia, Medellín, Antioquia, Colombia, ⁵University of Antioquia, Medellin, Antioquia, Colombia
Background/Purpose: Background: There is an increasing knowledge about the utility of urinary biomarkers for the diagnosis of lupus nephritis (LN) in patients with systemic lupus…

Abstracts tagged "lupus nephritis and biomarkers"

The Performance of a Renal Activity Index in Lupus Nephritis in Induction Therapy

Prognostic Value of Urinary Biomarkers for the Developing of End Stage Renal Disease in Patients with Systemic Lupus Erythematosus